Benzinga | Feb 25, 2021 08:10AM EST

Stifel Initiates Coverage On Precigen with Buy Rating, Announces Price Target of $13

Stifel analyst Benjamin Burnett initiates coverage on Precigen (NASDAQ:PGEN) with a Buy rating and announces Price Target of $13.